P435-0264 Screening compound: {2-[1-(1H-indol-2-ylcarbonyl)-4-piperidyl]-5-methyl-1,3-oxazol-4-yl}(1-pyrrolidinyl)methanone

P435-0264 Screening compound: {2-[1-(1H-indol-2-ylcarbonyl)-4-piperidyl]-5-methyl-1,3-oxazol-4-yl}(1-pyrrolidinyl)methanone
P435-0264 Screening compound: {2-[1-(1H-indol-2-ylcarbonyl)-4-piperidyl]-5-methyl-1,3-oxazol-4-yl}(1-pyrrolidinyl)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound P435-0264
{2-[1-(1H-indol-2-ylcarbonyl)-4-piperidyl]-5-methyl-1,3-oxazol-4-yl}(1-pyrrolidinyl)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P435-0264

Molecular Formula

C23H26N4O3 (C23 H26 N4 O3)

Compound Name

{2-[1-(1H-indol-2-ylcarbonyl)-4-piperidyl]-5-methyl-1,3-oxazol-4-yl}(1-pyrrolidinyl)methanone

IUPAC name

2-{4-[5-methyl-4-(pyrrolidine-1-carbonyl)-13-oxazol-2-yl]piperidine-1-carbonyl}-1H-indole

SMILES

Cc1c(C(N2CCCC2)=O)nc(C(CC2)CCN2C(c2cc(cccc3)c3[nH]2)=O)o1

InChI

InChI=1S/C23H26N4O3/c1-15-20(23(29)26-10-4-5-11-26)25-21(30-15)16-8-12-27(13-9-16)22(28)19-14-17-6-2-3-7-18(17)24-19/h2-3,6-7,14,16,24H,4-5,8-13H2,1H3

InChI Key

VMEFYUNHBOPHLR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27575036

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

406.48

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.506

Distribution Coefficient, logD

3.506

Water Solubility, LogSw

-3.58

Polar Surface Area

60.877

Acid Dissociation Constant (pKa)

15.07

Base Dissociation Constant (pKb)

-0.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.48

P435-0264 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Indole Derivatives (10091 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P435-0264 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P435-0264?
Check Price and Availability of P435-0264, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P435-0264 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P435-0264
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P435-0264
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P435-0264 available by request